Intravenous vitamin C use and risk of severity and mortality in COVID‐19: a systematic review and meta‐analysis

G Ao, J Li, Y Yuan, Y Wang, B Nasr… - Nutrition in Clinical …, 2022 - Wiley Online Library
The administration of intravenous vitamin C (IV‐VC) in treating patients with coronavirus
disease 2019 (COVID‐19) is still highly controversial. There have been no previous studies …

[HTML][HTML] High-dose vitamin C intravenous infusion in the treatment of patients with COVID-19: a protocol for systematic review and meta-analysis

L Huang, L Wang, J Tan, H Liu, Y Ni - Medicine, 2021 - journals.lww.com
Background: Patients infected with a virus usually lack vitamin C. High-dose vitamin C has
an antiviral effect, and has been used by several researchers to treat COVID-19 by …

[HTML][HTML] The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: a systematic review and meta-analysis

SG Kwak, YJ Choo, MC Chang - Complementary therapies in medicine, 2022 - Elsevier
Objectives Vitamin C has anti-inflammatory effects. This review aimed to investigate the
therapeutic effect of high-dose intravenous vitamin C (HDIVC) in patients with coronavirus …

Impact of high‐dose vitamin C on the mortality, severity, and duration of hospital stay in COVID‐19 patients: A meta‐analysis

KK Bhowmik, MA Barek, MA Aziz… - Health Science …, 2022 - Wiley Online Library
Abstract Background and Aims Vitamin C has been predicted to be effective as an
antioxidant in treating various ailments, including viral infections such as pervasive …

Vitamin C supplementation for the treatment of COVID-19: a systematic review and meta-analysis

M Olczak-Pruc, D Swieczkowski, JR Ladny, M Pruc… - Nutrients, 2022 - mdpi.com
Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, caused by the
severe respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of people have died …

Therapeutic effects of high-dose vitamin C supplementation in patients with COVID-19: a meta-analysis

L Sun, JH Zhao, WY Fan, B Feng, WW Liu… - Nutrition …, 2023 - academic.oup.com
Abstract Context Coronavirus disease 2019 (COVID-19) could induce the “cytokine storm”
due to overactivation of immune system and accompanied by acute respiratory distress …

High dose intravenous vitamin C for preventing the disease aggravation of moderate COVID-19 pneumonia. A retrospective propensity matched before-after study

B Zhao, M Liu, P Liu, Y Peng, J Huang, M Li… - Frontiers in …, 2021 - frontiersin.org
Background: Coronavirus disease 2019 (COVID-19) pandemic is continuing to impact
multiple countries worldwide and effective treatment options are still being developed. In this …

No significant benefit of moderate-dose vitamin C on severe COVID-19 cases

S Zheng, Q Chen, H Jiang, C Guo, J Luo, S Li… - Open …, 2021 - degruyter.com
There is no specific drug for coronavirus disease 2019 (COVID-19). We aimed to investigate
the possible clinical efficacy of moderate-dose vitamin C infusion among inpatients with …

[HTML][HTML] Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study

B Zhao, Y Ling, J Li, Y Peng, J Huang… - Annals of palliative …, 2021 - apm.amegroups.org
Background: Coronavirus disease 2019 (COVID-19) is a global public health event without
specific therapeutic agents till now. We aim to determine if high dose intravenous vitamin C …

Effect of vitamin C on clinical outcomes of critically ill patients with COVID-19: an observational study and subsequent meta-analysis

E Gavrielatou, E Xourgia, NA Xixi, AG Mantelou… - Frontiers in …, 2022 - frontiersin.org
Background Whether vitamin C provides any benefit when administered in critically ill
patients, including those with coronavirus disease (COVID-19), is controversial. We …